Trial of NanoPac Intratumoral Injection in Lung Cancer

NCT04314895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer, Nonsmall Cell
Lung Cancer
Lung Cancer, Small Cell
Neoplasm of Lung

Interventions

DRUG: NanoPac (sterile nanoparticulate paclitaxel) Powder for Suspension

Sponsor

NanOlogy, LLC

Collaborators

[object Object]